Finance

Lists
MFY:FRA
Mochida Pharmaceutical Co Ltd
€17,40
-0,57%
(-0,10) 1D
1 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MFY...
Open
€17,40
High
€17,40
Low
€17,40
Mkt. cap
112,63 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
€21,80
52-wk low
€16,20
No. of employees
1 k
Open
€17,40
High
€17,40
Low
€17,40
Mkt. cap
112,63 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
€21,80
52-wk low
€16,20
No. of employees
1 k
News stories
From web sources and news partners
Profile
Mochida Pharmaceutical Co., Ltd is a Japanese pharmaceutical company. One of its products is the antidepressant setiptiline. Wikipedia
About Mochida Pharmaceutical Co Ltd
CEO-
Employees1,48 k
Founded28 Apr. 1945
HeadquartersShinjuku City, Tokio, Japan
SectorPharmaceutical industry
Websitemochida.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
28,35 mjd
32,50 mjd
29,46 mjd
31,72 mjd
Cost of goods sold
15,13 mjd
17,50 mjd
15,06 mjd
17,03 mjd
Cost of revenue
15,13 mjd
17,50 mjd
15,06 mjd
17,03 mjd
Research and development expenses
-
-
12,16 mjd
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,83 mjd
12,45 mjd
-376,00 m
11,12 mjd
Operating expense
10,83 mjd
12,45 mjd
11,78 mjd
11,12 mjd
Total operating expenses
25,96 mjd
29,94 mjd
26,84 mjd
28,15 mjd
Operating income
2,40 mjd
2,56 mjd
2,62 mjd
3,56 mjd
Other non operating income
31,00 m
-67,00 m
12,00 m
34,00 m
EBT including unusual items
2,40 mjd
3,17 mjd
2,82 mjd
4,86 mjd
EBT excluding unusual items
2,40 mjd
3,17 mjd
2,85 mjd
4,19 mjd
Income tax expense
435,00 m
681,00 m
1,26 mjd
1,69 mjd
Effective tax rate
18,15%
21,50%
44,72%
34,68%
Other operating expenses
-
-
-
-
Net income
1,96 mjd
2,49 mjd
1,56 mjd
3,18 mjd
Net profit margin
6,92%
7,65%
5,30%
10,02%
Earnings per share
-
-
-
-
Interest and investment income
42,00 m
232,00 m
42,00 m
297,00 m
Interest expense
-1,00 m
-29,00 m
-42,00 m
-43,00 m
Net interest expenses
41,00 m
203,00 m
-
254,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
3,11 mjd
-
3,37 mjd
4,31 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme